2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

• Ruperto N,
• Lovell DJ,
• Cuttica R,
• Woo P,
• Espada G,
• Wouters C,
• Silverman ED,
• Balogh Z,
• Henrickson M,
• Davidson J,
• Foeldvari I,
• Imundo L,
• Simonini G,
• Oppermann J,
• Shen YK,
• Visvanathan S,
• Fasanmade A,
• Mendelsohn A,
• Martini A,
• Giannini EH

Affiliations

Ruperto N

Lovell DJ

Cuttica R

Woo P

Espada G

Wouters C

Silverman ED

Balogh Z

Henrickson M

Davidson J

Foeldvari I

Imundo L

Simonini G

Oppermann J

Shen YK

Visvanathan S

Fasanmade A

Mendelsohn A

Martini A

Giannini EH